Functional and cancer genomics of ASXL family members

British Journal of Cancer

Volumn 109, Issue 2, 2013, Pages 299-306

  Katoh, M ^a  

^a NATIONAL CANCER CENTER   (Japan)

Author keywords

chromosomal translocation; gene amplification; histone modification; nuclear hormone receptor; Polycomb group; truncation mutation

Indexed keywords

ADDITIONAL SEX COMBS LIKE 1 PROTEIN; ADDITIONAL SEX COMBS LIKE 2 PROTEIN; ADDITIONAL SEX COMBS LIKE 3 PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ADIPOCYTE; BREAST CANCER; CANCER GENETICS; CARCINOGENESIS; CELL DIFFERENTIATION; CHROMOSOME 18Q; CHROMOSOME 20Q; CHROMOSOME 2P; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOMONOCYTIC LEUKEMIA; COLORECTAL CANCER; DNA BINDING; DNA REPAIR; EMBRYO DEVELOPMENT; FUNCTIONAL GENOMICS; GENE MUTATION; GENETIC REGULATION; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; LIVER CANCER; MELANOMA; MICROSATELLITE INSTABILITY; MYELOPROLIFERATIVE NEOPLASM; NONHUMAN; PANCREAS CANCER; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN PROTEIN INTERACTION; REVIEW; T CELL LEUKEMIA; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; UBIQUITINATION; UTERINE CERVIX CANCER;

ADULT; AMINO ACID SEQUENCE; ANIMALS; GENOMICS; HUMANS; MOLECULAR SEQUENCE DATA; NEOPLASMS; PHYLOGENY; REPRESSOR PROTEINS; SEQUENCE HOMOLOGY; TRANSCRIPTION FACTORS;

EID: 84881108886     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2013.281     Document Type: Review

References (63)

1. Abdel-Wahab O, Adli M, LaFave LM, Gao J, Hricik T, Shih AH, Pandey S, Patel JP, Chung YR, Koche R, Perna F, Zhao X, Taylor JE, Park CY, Carroll M, Melnick A, Nimer SD, Jaffe JD, Aifantis I, Bernstein BE, Levine RL (2012) ASXL1 mutations promote myeloid transformation through loss of PRC2-mediated gene repression. Cancer Cell 22: 180-193.
2. Bainbridge MN, Hu H, Muzny DM, Musante L, Lupski JR, Graham BH, Chen W, Gripp KW, Jenny K, Wienker TF, Yang Y, Sutton VR, Gibbs RA, Ropers HH (2013) De novo truncating mutations in ASXL3 are associated with a novel clinical phenotype with similarities to Bohring-Opitz syndrome. Genome Med 5: 11.
3. Baskind HA, Na L, Ma Q, Patel MP, Geenen DL, Wang QT (2009) Functional conservation of Asxl2, a murine homolog for the Drosophila enhancer of trithorax and polycomb group gene Asx. PLoS One 4: E4750.
4. Berger MF, Hodis E, Heffernan TP, Deribe YL, Lawrence MS, Protopopov A, Ivanova E, Watson IR, Nickerson E, Ghosh P, Zhang H, Zeid R, Ren X, Cibulskis K, Sivachenko AY, Wagle N, Sucker A, Sougnez C, Onofrio R, Ambrogio L, Auclair D, Fennell T, Carter SL, Drier Y, Stojanov P, Singer MA, Voet D, Jing R, Saksena G, Barretina J, Ramos AH, Pugh TJ, Stransky N, Parkin M, Winckler W, Mahan S, Ardlie K, Baldwin J, Wargo J, Schadendorf D, Meyerson M, Gabriel SB, Golub TR, Wagner SN, Lander ES, Getz G, Chin L, Garraway LA (2012) Melanoma genome sequencing reveals frequent PREX2 mutations. Nature 485: 502-506.
5. Bischoff K, Ballew AC, Simon MA, O'Reilly AM (2009) Wing defects in Drosophila xenicid mutant clones are caused by C-terminal deletion of additional sex combs (Asx). PLoS One 4: E8106.
6. Breen TR, Duncan IM (1986) Maternal expression of genes that regulate the bithorax complex of Drosophila melanogaster. Dev Biol 118: 442-456.
7. Brock HW, Fisher CL (2005) Maintenance of gene expression patterns. Dev Dyn 232: 633-655.
8. Brock HW, van Lohuizen M (2001) The Polycomb group: No longer an exclusive club? Curr Opin Genet Dev 11: 175-181.
9. Campbell RB, Sinclair DA, Couling M, Brock HW (1995) Genetic interactions and dosage effects of Polycomb group genes of Drosophila. Mol Gen Genet 246: 291-300.
10. Carbuccia N, Murati A, Trouplin V, Brecqueville M, Adélaïde J, Rey J, Vainchenker W, Bernard OA, Chaffanet M, Vey N, Birnbaum D, Mozziconacci MJ (2009) Mutations of ASXL1 gene in myeloproliferative neoplasms. Leukemia 23: 2183-2186.
11. Cheng NN, Sinclair DA, Campbell RB, Brock HW (1994) Interactions of polyhomeotic with Polycomb group genes of Drosophila melanogaster. Genetics 138: 1151-1162.
12. Cho YS, Kim EJ, Park UH, Sin HS, Um SJ (2006) Additional sex comb-like 1 (ASXL1), in cooperation with SRC-1, acts as a ligand-dependent coactivator for retinoic acid receptor. J Biol Chem 28: 17588-17598.
13. Dey A, Seshasayee D, Noubade R, French DM, Liu J, Chaurushiya MS, Kirkpatrick DS, Pham VC, Lill JR, Bakalarski CE, Wu J, Phu L, Katavolos P, LaFave LM, Abdel-Wahab O, Modrusan Z, Seshagiri S, Dong K, Lin Z, Balazs M, Suriben R, Newton K, Hymowitz S, Garcia-Manero G, Martin F, Levine RL, Dixit VM (2012) Loss of the tumor suppressor BAP1 causes myeloid transformation. Science 337: 1541-1546.
14. Dietrich BH, Moore J, Kyba M, dosSantos G, McCloskey F, Milne TA, Brock HW, Krause HM (2001) Tantalus, a novel ASX-interacting protein with tissue-specific functions. Dev Biol 234: 441-453.
15. Farber CR, Bennett BJ, Orozco L, Zou W, Lira A, Kostem E, Kang HM, Furlotte N, Berberyan A, Ghazalpour A, Suwanwela J, Drake TA, Eskin E, Wang QT, Teitelbaum SL, Lusis AJ (2011) Mouse genome-wide association and systems genetics identify Asxl2 as a regulator of bone mineral density and osteoclastogenesis. PLoS Genet 7: E1002038.
16. Fisher CL, Berger J, Randazzo F, Brock HW (2003) A human homolog of Additional sex combs, ADDITIONAL SEX COMBS-LIKE 1, maps to chromosome 20q11. Gene 306: 115-126.
17. Fisher CL, Lee I, Bloyer S, Bozza S, Chevalier J, Dahl A, Bodner C, Helgason CD, Hess JL, Humphries RK, Brock HW (2010) Additional sex combs-like 1 belongs to the enhancer of trithorax and polycomb group and genetically interacts with Cbx2 in mice. Dev Biol 337: 9-15.
18. Fisher CL, Pineault N, Brookes C, Helgason CD, Ohta H, Bodner C, Hess JL, Humphries RK, Brock HW (2010) Loss-of-function Additional sex combs like 1 mutations disrupt hematopoiesis but do not cause severe myelodysplasia or leukemia. Blood 115: 38-46.
19. Gelsi-Boyer V, Brecqueville M, Devillier R, Murati A, Mozziconacci MJ, Birnbaum D (2012) Mutations in ASXL1 are associated with poor prognosis across the spectrum of malignant myeloid diseases. J Hematol Oncol 5: 12.
20. Gelsi-Boyer V, Trouplin V, Adélaïde J, Bonansea J, Cervera N, Carbuccia N, Lagarde A, Prebet T, Nezri M, Sainty D, Olschwang S, Xerri L, Chaffanet M, Mozziconacci MJ, Vey N, Birnbaum D (2009) Mutations of polycomb-associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemia. Br J Haematol 145: 788-800.
21. Gildea JJ, Lopez R, Shearn A (2000) A screen for new trithorax group genes identified little imaginal discs, the Drosophila melanogaster homologue of human retinoblastoma binding protein 2. Genetics 156: 645-663.
22. Grasso CS, Wu YM, Robinson DR, Cao X, Dhanasekaran SM, Khan AP, Quist MJ, Jing X, Lonigro RJ, Brenner JC, Asangani IA, Ateeq B, Chun SY, Siddiqui J, Sam L, Anstett M, Mehra R, Prensner JR, Palanisamy N, Ryslik GA, Vandin F, Raphael BJ, Kunju LP, Rhodes DR, Pienta KJ, Chinnaiyan AM, Tomlins SA (2012) The mutational landscape of lethal castration-resistant prostate cancer. Nature 487: 239-243.
23. Grimaud C, Nègre N, Cavalli G (2006) From genetics to epigenetics: The tale of Polycomb group and trithorax group genes. Chromosome Res 14: 363-375.
24. Halachmi N, Schulze KL, Inbal A, Salzberg A (2007) Additional sex combs affects antennal development by means of spatially restricted repression of Antp and wg. Dev Dyn 236: 2118-2130.
25. Hoischen A, van Bon BW, Rodríguez-Santiago B, Gilissen C, Vissers LE, de Vries P, Janssen I, van Lier B, Hastings R, Smithson SF, Newbury-Ecob R, Kjaergaard S, Goodship J, McGowan R, Bartholdi D, Rauch A, Peippo M, Cobben JM, Wieczorek D, Gillessen-Kaesbach G, Veltman JA, Brunner HG, de Vries BB (2011) De novo nonsense mutations in ASXL1 cause Bohring-Opitz syndrome. Nat Genet 43: 729-731.
26. Jee SW, Cho JS, Kim CK, Hwang DY, Shim SB, Lee SH, Sin JS, Kim YS, Park JH, Lee SH, Choi SY, Kim YK (2007) Analysis of differentially expressed genes in early- and late-stage APPsw-transgenic and normal mice using cDNA microarray. Int J Mol Med 19: 461-468.
27. Jensen DE, Proctor M, Marquis ST, Gardner HP, Ha SI, Chodosh LA, Ishov AM, Tommerup N, Vissing H, Sekido Y, Minna J, Borodovsky A, Schultz DC, Wilkinson KD, Maul GG, Barlev N, Berger SL, Prendergast GC, Rauscher 3rd FJ (1998) BAP1: A novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression. Oncogene 16: 1097-1112.
28. Jones S, Zhang X, Parsons DW, Lin JC, Leary RJ, Angenendt P, Mankoo P, Carter H, Kamiyama H, Jimeno A, Hong SM, Fu B, Lin MT, Calhoun ES, Kamiyama M, Walter K, Nikolskaya T, Nikolsky Y, Hartigan J, Smith DR, Hidalgo M, Leach SD, Klein AP, Jaffee EM, Goggins M, Maitra A, Iacobuzio-Donahue C, Eshleman JR, Kern SE, Hruban RH, Karchin R, Papadopoulos N, Parmigiani G, Vogelstein B, Velculescu VE, Kinzler KW (2008) Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 321: 1801-1806.
29. Jürgens G (1985) A group of genes controlling the spatial expression of the bithorax complex in Drosophila. Nature 316: 153-155.
30. Katoh M, Igarashi M, Fukuda H, Nakagama H, Katoh M (2013) Cancer genetics and genomics of human FOX family genes. Cancer Lett 328: 198-206.
31. Katoh M, Katoh M (2003) Identification and characterization of ASXL2 gene in silico. Int J Oncol 23: 845-850.
32. Katoh M, Katoh M (2004) Identification and characterization of ASXL3 gene in silico. Int J Oncol 24: 1617-1622.
33. Lee SW, Cho YS, Na JM, Park UH, Kang M, Kim EJ, Um SJ (2010) ASXL1 represses retinoic acid receptor-mediated transcription through associating with HP1 and LSD1. J Biol Chem 285: 18-29.
34. Li M, Zhao H, Zhang X, Wood LD, Anders RA, Choti MA, Pawlik TM, Daniel HD, Kannangai R, Offerhaus GJ, Velculescu VE, Wang L, Zhou S, Vogelstein B, Hruban RH, Papadopoulos N, Cai J, Torbenson MS, Kinzler KW (2011) Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma. Nat Genet 43: 828-829.
35. Li Y, Li H (2012) Many keys to push: Diversifying the 'readership' of plant homeodomain fingers. Acta Biochim Biophys Sin 44: 28-39.
36. Liu L, Qin S, Zhang J, Ji P, Shi Y, Wu J (2012) Solution structure of an atypical PHD finger in BRPF2 and its interaction with DNA. J Struct Biol 180: 165-173.
37. Metzeler KH, Becker H,Maharry K, Radmacher MD, Kohlschmidt J,Mrózek K, Nicolet D, Whitman SP, Wu YZ, Schwind S, Powell BL, Carter TH, Wetzler M, Moore JO, Kolitz JE, Baer MR, Carroll AJ, Larson RA, Caligiuri MA, Marcucci G, Bloomfield CD (2011) ASXL1 mutations identify a high-risk subgroup of older patients with primary cytogenetically normal AML within the ELN favorable genetic category. Blood 118: 6920-6929.
38. Milne TA, Sinclair DA, Brock HW (1999) The Additional sex combs gene of Drosophila is required for activation and repression of homeotic loci, and interacts specifically with Polycomb and super sex combs. Mol Gen Genet 261: 753-761.
39. Müller J, Verrijzer P (2009) Biochemical mechanisms of gene regulation by polycomb group protein complexes. Curr Opin Genet Dev 19: 150-158.
40. Nakahata S, Saito Y, Hamasaki M, Hidaka T, Arai Y, Taki T, Taniwaki M, Morishita K (2009) Alteration of enhancer of polycomb 1 at 10p11.2 is one of the genetic events leading to development of adult T-cell leukemia/lymphoma. Genes Chromosomes Cancer 48: 768-776.
41. Park UH, Yoon SK, Park T, Kim EJ, Um SJ (2011) Additional sex comb-like (ASXL) proteins 1 and 2 play opposite roles in adipogenesis via reciprocal regulation of peroxisome proliferator-activated receptor g. J Biol Chem 286: 1354-1363.
42. Petruk S, Smith ST, Sedkov Y, Mazo A (2008) Association of trxG and PcG proteins with the bxd maintenance element depends on transcriptional activity. Development 135: 2383-2390.
43. Pietersen AM, van Lohuizen M (2008) Stem cell regulation by polycomb repressors: Postponing commitment. Curr Opin Cell Biol 20: 201-207.
44. Quesada V, Conde L, Villamor N, Ordóñez GR, Jares P, Bassaganyas L, Ramsay AJ, Beà S, Pinyol M, Martínez-Trillos A, López-Guerra M, Colomer D, Navarro A, Baumann T, Aymerich M, Rozman M, Delgado J, Giné E, Hernández JM, González-Díaz M, Puente DA, Velasco G, Freije JM, Tubío JM, Royo R, Gelpí JL, Orozco M, Pisano DG, Zamora J, Vázquez M, Valencia A, Himmelbauer H, Bayés M, Heath S, Gut M, Gut I, Estivill X, López-Guillermo A, Puente XS, Campo E, López-Otín C (2011) Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia. Nat Genet 44: 47-52.
45. Sanchez R, Zhou MM (2011) The PHD finger: A versatile epigenome reader. Trends Biochem Sci 36: 364-372.
46. Sanchez-Pulido L, Kong L, Ponting CP (2012) A common ancestry for BAP1 and Uch37 regulators. Bioinformatics 28: 1953-1956.
47. Scheuermann JC, de Ayala Alonso AG, Oktaba K, Ly-Hartig N, McGinty RK, Fraterman S, Wilm M, Muir TW, Müller J (2010) Histone H2A deubiquitinase activity of the Polycomb repressive complex PR-DUB. Nature 465: 243-247.
48. Schuettengruber B, Chourrout D, Vervoort M, Leblanc B, Cavalli G (2007) Genome regulation by polycomb and trithorax proteins. Cell 128: 735-745.
49. Schwartz YB, Pirrotta V (2007) Polycomb silencing mechanisms and the management of genomic programmes. Nat Rev Genet 8: 9-22.
50. Scotto L, Narayan G, Nandula SV, Arias-Pulido H, Subramaniyam S, Schneider A, Kaufmann AM, Wright JD, Pothuri B, Mansukhani M, Murty VV (2008) Identification of copy number gain and overexpressed genes on chromosome arm 20q by an integrative genomic approach in cervical cancer: Potential role in progression. Genes Chromosomes Cancer 47: 755-765.
51. Simon J, Chiang A, Bender W (1992) Ten different Polycomb group genes are required for spatial control of the abdA and AbdB homeotic products. Development 114: 493-505.
52. Simon J, Chiang A, Bender W, Shimell MJ, O0Connor M (1993) Elements of the Drosophila bithorax complex that mediate repression by Polycomb group products. Dev Biol 158: 131-144.
53. Simon JA, Kingston RE (2009) Mechanisms of Polycomb gene silencing: Knowns and unknowns. Nat Rev Mol Cell Biol 10: 697-708.
54. Sinclair DA, Campbell RB, Nicholls F, Slade E, Brock HW (1992) Genetic analysis of the Additional sex combs locus of Drosophila melanogaster. Genetics 130: 817-825.
55. Sinclair DA, Milne TA, Hodgson JW, Shellard J, Salinas CA, Kyba M, Randazzo F, Brock HW (1998) The Additional sex combs gene of Drosophila encodes a chromatin protein that binds to shared and unique Polycomb group sites on polytene chromosomes. Development 125: 1207-1216.
56. Sowa ME, Bennett EJ, Gygi SP, Harper JW (2009) Defining the human deubiquitinating enzyme interaction landscape. Cell 138: 389-403.
57. Sparmann A, van Lohuizen M (2006) Polycomb silencers control cell fate, development and cancer. Nat Rev Cancer 6: 846-856.
58. Stephens PJ, Tarpey PS, Davies H, Van Loo P, Greenman C, Wedge DC, Nik-Zainal S, Martin S, Varela I, Bignell GR, Yates LR, Papaemmanuil E, Beare D, Butler A, Cheverton A, Gamble J, Hinton J, Jia M, Jayakumar A, Jones D, Latimer C, Lau KW, McLaren S, McBride DJ, Menzies A, Mudie L, Raine K, Rad R, Chapman MS, Teague J, Easton D, Langerød A, Oslo Breast Cancer Consortium (OSBREAC), Lee MT, Shen CY, Tee BT, Huimin BW, Broeks A, Vargas AC, Turashvili G, Martens J, Fatima A, Miron P, Chin SF, Thomas G, Boyault S, Mariani O, Lakhani SR, van de Vijver M, van 0t Veer L, Foekens J, Desmedt C, Sotiriou C, Tutt A, Caldas C, Reis-Filho JS, Aparicio SA, Salomon AV, Børresen-Dale AL, Richardson AL, Campbell PJ, Futreal PA, Stratton MR. (2012) The landscape of cancer genes and mutational processes in breast cancer. Nature 486: 400-404.
59. Stransky N, Egloff AM, Tward AD, Kostic AD, Cibulskis K, Sivachenko A, Kryukov GV, Lawrence MS, Sougnez C, McKenna A, Shefler E, Ramos AH, Stojanov P, Carter SL, Voet D, Cortés ML, Auclair D, Berger MF, Saksena G, Guiducci C, Onofrio RC, Parkin M, Romkes M, Weissfeld JL, Seethala RR, Wang L, Rangel-Escareño C, Fernandez-Lopez JC, Hidalgo-Miranda A, Melendez-Zajgla J, Winckler W, Ardlie K, Gabriel SB, Meyerson M, Lander ES, Getz G, Golub TR, Garraway LA, Grandis Jr. (2011) The mutational landscape of head and neck squamous cell carcinoma. Science 333: 1157-1160.
60. Tefferi A (2010) Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1. Leukemia 24: 1128-1138.
61. Vardiman JW, Thiele J, Arber DA, Brunning RD, Borowitz MJ, Porwit A, Harris NL, Le Beau MM, Hellström-Lindberg E, Tefferi A, Bloomfield CD (2009) The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: Rationale and important changes. Blood 114: 937-951.
62. Williams DS, Bird MJ, Jorissen RN, Yu YL, Walker F, Zhang HH, Nice EC, Burgess AW (2010) Nonsense mediated decay resistant mutations are a source of expressed mutant proteins in colon cancer cell lines with microsatellite instability. PLoS One 5: E16012.
63. Yu H, Mashtalir N, Daou S, Hammond-Martel I, Ross J, Sui G, Hart GW, Rauscher 3rd FJ, Drobetsky E, Milot E, Shi Y, Affar EB (2010) The ubiquitin carboxyl hydrolase BAP1 forms a ternary complex with YY1 and HCF-1 and is a critical regulator of gene expression. Mol Cell Biol 30: 5071-5085.